⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
FENC News
Fennec Pharmaceuticals Inc. Common Stock
Fennec Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
globenewswire.com
FENC
Fennec Pharmaceuticals to Report Full Year and Fourth Quarter 2025 Financial Results on March 24, 2026
globenewswire.com
FENC
Form 8-K
sec.gov
FENC
Fennec Pharmaceuticals Announces Settlement Agreement Resolving PEDMARK Patent Litigation
globenewswire.com
FENC
Form 8-K
sec.gov
FENC
Fennec Pharmaceuticals Announces Clinical Research Collaboration with Tampa General Hospital Cancer Institute
globenewswire.com
FENC
Form 8-K
sec.gov
FENC
Fennec Pharmaceuticals Presents Real World Data Supporting the Integration and Clinical Use of PEDMARK® in Treating Adults with Head & Neck Cancers
globenewswire.com
FENC
Fennec Pharmaceuticals Announces Investigator-Sponsored Trial to Be Conducted by City of Hope in Metastatic Testicular Germ Cell Tumors
globenewswire.com
FENC
Fennec Pharmaceuticals Announces Positive Topline Results From Investigator-Initiated Clinical Study of PEDMARK® in Japan to Reduce Cisplatin-Induced Hearing Loss
globenewswire.com
FENC